Bendheim Daniel M
Known title: Exec. VP, Corporate StrategyCIK: 0001601576
Associated companies
Transaction History
| PAHC | ▲ Buy | Grant | 11,699 | $0 | 8/6/2026 | View on chart |
| PAHC | ▼ Sell | Other | 486 | $18K | 8/4/2026 | View on chart |
| PAHC | ▲ Buy | Grant | 3,964 | $0 | 8/15/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review
Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.
Phibro Animal Health (PAHC) Draws Attention Amid Small-Cap Review. Phibro Animal Health (PAHC) is currently the focus of market attention, with recent articles discussing whether it is the right time to hold the stock. The company is also highlighted in a list of small-cap stocks showing warning signs. This news provides context for the stock's current position within its 52-week range, which spans from $28.25 to $60.08.